Global Short Bowel Syndrome (SBS) Drugs Market Insights and Forecast to 2028

Publisher Name :
Date: 28-Feb-2022
No. of pages: 93
Inquire Before Buying

Short Bowel Syndrome(SBS) Drugs market is segmented by Type and by Sale Channel. Players, stakeholders, and other participants in the global Short Bowel Syndrome(SBS) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sale Channel for the period 2017-2028.

Segment by Type

- Glucagon-Like Peptide-2(GLP-2)

- Growth Hormone

- Glutamine

- Other

Segment by Sale Channel

- Hospitals

- Clinics

- Retail Pharmacies

By Company

- Merck

- Takeda

- Emmaus Medical

- Ardelyx

- Naia Pharmaceuticals

- Nutrinia

- OxThera

- Sancilio Pharmaceuticals

- Zealand Pharma

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Short Bowel Syndrome (SBS) Drugs Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Short Bowel Syndrome(SBS) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Short Bowel Syndrome(SBS) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Glucagon-Like Peptide-2(GLP-2)
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Market by Sale Channel
1.3.1 Global Short Bowel Syndrome(SBS) Drugs Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Short Bowel Syndrome(SBS) Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Short Bowel Syndrome(SBS) Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Short Bowel Syndrome(SBS) Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Short Bowel Syndrome(SBS) Drugs Sales by Region
2.4.1 Global Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Short Bowel Syndrome(SBS) Drugs by Region (2023-2028)
2.5 Global Short Bowel Syndrome(SBS) Drugs Revenue by Region
2.5.1 Global Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2022)
2.5.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Short Bowel Syndrome(SBS) Drugs Sales by Manufacturers
3.1.1 Global Top Short Bowel Syndrome(SBS) Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Short Bowel Syndrome(SBS) Drugs in 2021
3.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Manufacturers
3.2.1 Global Short Bowel Syndrome(SBS) Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Short Bowel Syndrome(SBS) Drugs Revenue in 2021
3.3 Global Short Bowel Syndrome(SBS) Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Short Bowel Syndrome(SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Short Bowel Syndrome(SBS) Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Short Bowel Syndrome(SBS) Drugs Sales by Type
4.1.1 Global Short Bowel Syndrome(SBS) Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Short Bowel Syndrome(SBS) Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2028)
4.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Type
4.2.1 Global Short Bowel Syndrome(SBS) Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Short Bowel Syndrome(SBS) Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Short Bowel Syndrome(SBS) Drugs Price by Type
4.3.1 Global Short Bowel Syndrome(SBS) Drugs Price by Type (2017-2022)
4.3.2 Global Short Bowel Syndrome(SBS) Drugs Price Forecast by Type (2023-2028)
5 Market Size by Sale Channel
5.1 Global Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
5.1.1 Global Short Bowel Syndrome(SBS) Drugs Historical Sales by Sale Channel (2017-2022)
5.1.2 Global Short Bowel Syndrome(SBS) Drugs Forecasted Sales by Sale Channel (2023-2028)
5.1.3 Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2028)
5.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel
5.2.1 Global Short Bowel Syndrome(SBS) Drugs Historical Revenue by Sale Channel (2017-2022)
5.2.2 Global Short Bowel Syndrome(SBS) Drugs Forecasted Revenue by Sale Channel (2023-2028)
5.2.3 Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel (2017-2028)
5.3 Global Short Bowel Syndrome(SBS) Drugs Price by Sale Channel
5.3.1 Global Short Bowel Syndrome(SBS) Drugs Price by Sale Channel (2017-2022)
5.3.2 Global Short Bowel Syndrome(SBS) Drugs Price Forecast by Sale Channel (2023-2028)
6 North America
6.1 North America Short Bowel Syndrome(SBS) Drugs Market Size by Type
6.1.1 North America Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2028)
6.1.2 North America Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2028)
6.2 North America Short Bowel Syndrome(SBS) Drugs Market Size by Sale Channel
6.2.1 North America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2028)
6.2.2 North America Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2028)
6.3 North America Short Bowel Syndrome(SBS) Drugs Market Size by Country
6.3.1 North America Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2028)
6.3.2 North America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Short Bowel Syndrome(SBS) Drugs Market Size by Type
7.1.1 Europe Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2028)
7.1.2 Europe Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2028)
7.2 Europe Short Bowel Syndrome(SBS) Drugs Market Size by Sale Channel
7.2.1 Europe Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2028)
7.2.2 Europe Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2028)
7.3 Europe Short Bowel Syndrome(SBS) Drugs Market Size by Country
7.3.1 Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2028)
7.3.2 Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Short Bowel Syndrome(SBS) Drugs Market Size by Type
8.1.1 Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Short Bowel Syndrome(SBS) Drugs Market Size by Sale Channel
8.2.1 Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2028)
8.2.2 Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2028)
8.3 Asia Pacific Short Bowel Syndrome(SBS) Drugs Market Size by Region
8.3.1 Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Short Bowel Syndrome(SBS) Drugs Market Size by Type
9.1.1 Latin America Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2028)
9.1.2 Latin America Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2028)
9.2 Latin America Short Bowel Syndrome(SBS) Drugs Market Size by Sale Channel
9.2.1 Latin America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2028)
9.2.2 Latin America Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2028)
9.3 Latin America Short Bowel Syndrome(SBS) Drugs Market Size by Country
9.3.1 Latin America Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2028)
9.3.2 Latin America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Market Size by Type
10.1.1 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Market Size by Sale Channel
10.2.1 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2028)
10.2.2 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2028)
10.3 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Market Size by Country
10.3.1 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Takeda
11.2.1 Takeda Corporation Information
11.2.2 Takeda Overview
11.2.3 Takeda Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Takeda Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Takeda Recent Developments
11.3 Emmaus Medical
11.3.1 Emmaus Medical Corporation Information
11.3.2 Emmaus Medical Overview
11.3.3 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Emmaus Medical Recent Developments
11.4 Ardelyx
11.4.1 Ardelyx Corporation Information
11.4.2 Ardelyx Overview
11.4.3 Ardelyx Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ardelyx Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ardelyx Recent Developments
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Corporation Information
11.5.2 Naia Pharmaceuticals Overview
11.5.3 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Naia Pharmaceuticals Recent Developments
11.6 Nutrinia
11.6.1 Nutrinia Corporation Information
11.6.2 Nutrinia Overview
11.6.3 Nutrinia Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Nutrinia Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Nutrinia Recent Developments
11.7 OxThera
11.7.1 OxThera Corporation Information
11.7.2 OxThera Overview
11.7.3 OxThera Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 OxThera Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 OxThera Recent Developments
11.8 Sancilio Pharmaceuticals
11.8.1 Sancilio Pharmaceuticals Corporation Information
11.8.2 Sancilio Pharmaceuticals Overview
11.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sancilio Pharmaceuticals Recent Developments
11.9 Zealand Pharma
11.9.1 Zealand Pharma Corporation Information
11.9.2 Zealand Pharma Overview
11.9.3 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Zealand Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Short Bowel Syndrome(SBS) Drugs Industry Chain Analysis
12.2 Short Bowel Syndrome(SBS) Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Short Bowel Syndrome(SBS) Drugs Production Mode & Process
12.4 Short Bowel Syndrome(SBS) Drugs Sales and Marketing
12.4.1 Short Bowel Syndrome(SBS) Drugs Sales Channels
12.4.2 Short Bowel Syndrome(SBS) Drugs Distributors
12.5 Short Bowel Syndrome(SBS) Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Short Bowel Syndrome(SBS) Drugs Industry Trends
13.2 Short Bowel Syndrome(SBS) Drugs Market Drivers
13.3 Short Bowel Syndrome(SBS) Drugs Market Challenges
13.4 Short Bowel Syndrome(SBS) Drugs Market Restraints
14 Key Findings in The Global Short Bowel Syndrome(SBS) Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Short Bowel Syndrome(SBS) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Glucagon-Like Peptide-2(GLP-2)
Table 3. Major Manufacturers of Growth Hormone
Table 4. Major Manufacturers of Glutamine
Table 5. Major Manufacturers of Other
Table 6. Global Short Bowel Syndrome(SBS) Drugs Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Short Bowel Syndrome(SBS) Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 9. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Short Bowel Syndrome(SBS) Drugs Sales by Region (2023-2028) & (K Pcs)
Table 11. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2023-2028)
Table 12. Global Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global Short Bowel Syndrome(SBS) Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region (2023-2028)
Table 16. Global Short Bowel Syndrome(SBS) Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 17. Global Short Bowel Syndrome(SBS) Drugs Sales Share by Manufacturers (2017-2022)
Table 18. Global Short Bowel Syndrome(SBS) Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Short Bowel Syndrome(SBS) Drugs Revenue Share by Manufacturers (2017-2022)
Table 20. Short Bowel Syndrome(SBS) Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 21. Global Short Bowel Syndrome(SBS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Short Bowel Syndrome(SBS) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome(SBS) Drugs as of 2021)
Table 23. Short Bowel Syndrome(SBS) Drugs Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Short Bowel Syndrome(SBS) Drugs Product Offered
Table 25. Date of Manufacturers Enter into Short Bowel Syndrome(SBS) Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 28. Global Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 29. Global Short Bowel Syndrome(SBS) Drugs Sales Share by Type (2017-2022)
Table 30. Global Short Bowel Syndrome(SBS) Drugs Sales Share by Type (2023-2028)
Table 31. Global Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Short Bowel Syndrome(SBS) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Short Bowel Syndrome(SBS) Drugs Revenue Share by Type (2017-2022)
Table 34. Global Short Bowel Syndrome(SBS) Drugs Revenue Share by Type (2023-2028)
Table 35. Short Bowel Syndrome(SBS) Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 36. Global Short Bowel Syndrome(SBS) Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 37. Global Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 38. Global Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 39. Global Short Bowel Syndrome(SBS) Drugs Sales Share by Sale Channel (2017-2022)
Table 40. Global Short Bowel Syndrome(SBS) Drugs Sales Share by Sale Channel (2023-2028)
Table 41. Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 42. Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 43. Global Short Bowel Syndrome(SBS) Drugs Revenue Share by Sale Channel (2017-2022)
Table 44. Global Short Bowel Syndrome(SBS) Drugs Revenue Share by Sale Channel (2023-2028)
Table 45. Short Bowel Syndrome(SBS) Drugs Price by Sale Channel (2017-2022) & (USD/Pcs)
Table 46. Global Short Bowel Syndrome(SBS) Drugs Price Forecast by Sale Channel (2023-2028) & (USD/Pcs)
Table 47. North America Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 48. North America Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 49. North America Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Short Bowel Syndrome(SBS) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 52. North America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 53. North America Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 54. North America Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 55. North America Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 56. North America Short Bowel Syndrome(SBS) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 57. North America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 61. Europe Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Short Bowel Syndrome(SBS) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 64. Europe Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 65. Europe Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 66. Europe Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 67. Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 68. Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 69. Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 72. Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 73. Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 76. Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 77. Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 78. Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 79. Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 80. Asia Pacific Short Bowel Syndrome(SBS) Drugs Sales by Region (2023-2028) & (K Pcs)
Table 81. Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Short Bowel Syndrome(SBS) Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 84. Latin America Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 85. Latin America Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Short Bowel Syndrome(SBS) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 88. Latin America Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 89. Latin America Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 90. Latin America Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 91. Latin America Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 92. Latin America Short Bowel Syndrome(SBS) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 93. Latin America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Short Bowel Syndrome(SBS) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 96. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 97. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 100. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 101. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 104. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 105. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 107. Merck Corporation Information
Table 108. Merck Description and Major Businesses
Table 109. Merck Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Merck Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. Takeda Corporation Information
Table 113. Takeda Description and Major Businesses
Table 114. Takeda Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Takeda Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Takeda Recent Developments
Table 117. Emmaus Medical Corporation Information
Table 118. Emmaus Medical Description and Major Businesses
Table 119. Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Emmaus Medical Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Emmaus Medical Recent Developments
Table 122. Ardelyx Corporation Information
Table 123. Ardelyx Description and Major Businesses
Table 124. Ardelyx Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. Ardelyx Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Ardelyx Recent Developments
Table 127. Naia Pharmaceuticals Corporation Information
Table 128. Naia Pharmaceuticals Description and Major Businesses
Table 129. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Naia Pharmaceuticals Recent Developments
Table 132. Nutrinia Corporation Information
Table 133. Nutrinia Description and Major Businesses
Table 134. Nutrinia Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 135. Nutrinia Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Nutrinia Recent Developments
Table 137. OxThera Corporation Information
Table 138. OxThera Description and Major Businesses
Table 139. OxThera Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 140. OxThera Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. OxThera Recent Developments
Table 142. Sancilio Pharmaceuticals Corporation Information
Table 143. Sancilio Pharmaceuticals Description and Major Businesses
Table 144. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 145. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sancilio Pharmaceuticals Recent Developments
Table 147. Zealand Pharma Corporation Information
Table 148. Zealand Pharma Description and Major Businesses
Table 149. Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 150. Zealand Pharma Short Bowel Syndrome(SBS) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Zealand Pharma Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Short Bowel Syndrome(SBS) Drugs Distributors List
Table 155. Short Bowel Syndrome(SBS) Drugs Customers List
Table 156. Short Bowel Syndrome(SBS) Drugs Market Trends
Table 157. Short Bowel Syndrome(SBS) Drugs Market Drivers
Table 158. Short Bowel Syndrome(SBS) Drugs Market Challenges
Table 159. Short Bowel Syndrome(SBS) Drugs Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Short Bowel Syndrome(SBS) Drugs Product Picture
Figure 3. Global Short Bowel Syndrome(SBS) Drugs Market Share by Type in 2021 & 2028
Figure 3. Glucagon-Like Peptide-2(GLP-2) Product Picture
Figure 4. Growth Hormone Product Picture
Figure 5. Glutamine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Short Bowel Syndrome(SBS) Drugs Market Share by Sale Channel in 2021 & 2028
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Retail Pharmacies
Figure 11. Short Bowel Syndrome(SBS) Drugs Report Years Considered
Figure 12. Global Short Bowel Syndrome(SBS) Drugs Sales 2017-2028 (K Pcs)
Figure 13. Global Short Bowel Syndrome(SBS) Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Short Bowel Syndrome(SBS) Drugs Revenue 2017-2028 (US$ Million)
Figure 15. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2023-2028)
Figure 18. North America Short Bowel Syndrome(SBS) Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 19. North America Short Bowel Syndrome(SBS) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Short Bowel Syndrome(SBS) Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 21. Europe Short Bowel Syndrome(SBS) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 23. Asia-Pacific Short Bowel Syndrome(SBS) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Short Bowel Syndrome(SBS) Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 25. Latin America Short Bowel Syndrome(SBS) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 27. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Short Bowel Syndrome(SBS) Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Short Bowel Syndrome(SBS) Drugs in the World: Market Share by Short Bowel Syndrome(SBS) Drugs Revenue in 2021
Figure 30. Global Short Bowel Syndrome(SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2028)
Figure 34. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel (2017-2028)
Figure 35. North America Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type (2017-2028)
Figure 37. North America Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2028)
Figure 38. North America Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel (2017-2028)
Figure 39. North America Short Bowel Syndrome(SBS) Drugs Sales Share by Country (2017-2028)
Figure 40. North America Short Bowel Syndrome(SBS) Drugs Revenue Share by Country (2017-2028)
Figure 41. U.S. Short Bowel Syndrome(SBS) Drugs Revenue (2017-
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs